Compare DOOO & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DOOO | MMSI |
|---|---|---|
| Founded | 1937 | 1987 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 4.8B |
| IPO Year | N/A | 1990 |
| Metric | DOOO | MMSI |
|---|---|---|
| Price | $76.66 | $86.63 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 8 |
| Target Price | $77.40 | ★ $105.38 |
| AVG Volume (30 Days) | 183.2K | ★ 674.7K |
| Earning Date | 12-04-2025 | 10-30-2025 |
| Dividend Yield | ★ 0.80% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.24 | ★ 1.95 |
| Revenue | ★ $5,730,422,869.00 | $1,477,128,000.00 |
| Revenue This Year | $6.06 | $13.53 |
| Revenue Next Year | $6.25 | $6.30 |
| P/E Ratio | $322.50 | ★ $44.43 |
| Revenue Growth | N/A | ★ 11.41 |
| 52 Week Low | $31.78 | $78.12 |
| 52 Week High | $78.07 | $111.45 |
| Indicator | DOOO | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 79.85 | 55.48 |
| Support Level | $68.61 | $82.68 |
| Resistance Level | $78.07 | $88.71 |
| Average True Range (ATR) | 2.33 | 1.65 |
| MACD | 1.20 | 0.02 |
| Stochastic Oscillator | 91.82 | 65.34 |
BRP designs, develops, manufactures, distributes, and markets snowmobiles, all-terrain vehicles, and personal watercraft under the Ski-Doo, Sea-Doo, Can-Am, and Lynx brand names. It also builds engines under the Rotax brand (after shuttering the Evinrude outboard engine business in 2020) and offers clothing, parts, and accessories that cater to its core consumers. In 2018, BRP created a marine group, which has largely been divested (Manitou pontoon boats sale is set to close in the third quarter). At the end of fiscal 2025, the company sold its products through a network of more than 2,400 independent dealers and 140 distributors in around 130 countries.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.